LISA CORDOVA: Open Payments
NPI 1225408271 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 58 payments from 15 companies in 2025. Trend: 2023 $1,856 · 2024 $1,592 · 2025 $1,145
Food & beverage: $1,145
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 14 | $201 |
| Novartis Pharmaceuticals Corporation | 6 | $148 |
| GENZYME CORPORATION | 7 | $148 |
| E.R. Squibb & Sons, L.L.C. | 4 | $100 |
| Regeneron Healthcare Solutions, Inc. | 4 | $81 |
| Janssen Biotech, Inc. | 4 | $73 |
| Almirall LLC | 3 | $63 |
| Galderma Laboratories, L.P. | 4 | $62 |
| Lilly USA, LLC | 2 | $56 |
| ABBVIE INC. | 2 | $55 |
Products named: DUPIXENT, Bimzelx, Sotyktu, TREMFYA, Seysara, NEMLUVIO, COSENTYX, OTEZLA.
Industry payments across TX — which companies pay providers there.
